RUNX2 and ossifying fibroma: The GCs of tenosynovial GC tumour were RUNX2-positive throughout, while the GCs of non-ossifying fibroma were up to 30% RUNX2-positive, and the GCs of chondroblastoma and xanthogranuloma did not show immunoreactivity for RUNX2.